Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective <scp>QOLIXANE</scp> trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registrySalah‐Eddin Al‐Batran, Ursula Vehling‐Kaiser, Michael Koenigsmann et al.|International Journal of Cancer|2020Cited by 21
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registryMartin Metzenmacher, Wilfried Eberhardt, Frank Griesinger et al.|European Respiratory Journal|2022Cited by 17
Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemiaMoritz Fürstenau, Anna‐Maria Fink, Adam Giza et al.|American Journal of Hematology|2021Cited by 9
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)Frank Griesinger, Dimitri Flieger, Wilfried Eberhardt et al.|JTO Clinical and Research Reports|2023Cited by 4